Simon B. Zeichner

Cost-Effectiveness of Immune Checkpoint Inhibition in<i>BRAF</i>Wild-Type Advanced Melanoma

Christine G. Kohn, Simon B. Zeichner, Qiushi Chen et al. · Journal of Clinical Oncology · 2017 · 105 citations

Cancer Management, Immunology, Pathology +18

Improved Clinical Outcomes Associated With Vitamin D Supplementation During Adjuvant Chemotherapy in Patients With HER2+ Nonmetastatic Breast Cancer

Simon B. Zeichner, Tulay Koru‐Sengul, Nikesh Shah et al. · Clinical Breast Cancer · 2014 · 83 citations

Breast Oncology, Medicine, Cancer Management +5

Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States

Vakaramoko Diaby, Georges Adunlin, Askal Ayalew Ali et al. · Breast Cancer Research and Treatment · 2016 · 47 citations · Full text

Breast Oncology, Cost-effectiveness Analysis, Line Sequential +6

Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia

Betty K. Hamilton, Lisa Rybicki, Donna Abounader et al. · Biology of Blood and Marrow Transplantation · 2017 · 35 citations · Full text

Reducing Blood Utilization by Implementation of a Type-and-Screen Transfusion Policy A Single-Institution Experience

Sarah Alghamdi, B Pascual Gonzalez, Lydia Howard et al. · American Journal of Clinical Pathology · 2014 · 22 citations · Full text